Renaissance Technologies’s Aptevo Therapeutics APVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-49
Closed -$6.58K 3553
2024
Q3
$6.58K Buy
+49
New +$6.58K ﹤0.01% 3474
2024
Q1
Sell
-16
Closed -$94K 3684
2023
Q4
$94K Buy
16
+11
+220% +$64.6K ﹤0.01% 3315
2023
Q3
$58K Buy
5
+3
+150% +$34.8K ﹤0.01% 3374
2023
Q2
$117K Hold
2
﹤0.01% 3435
2023
Q1
$112K Hold
2
﹤0.01% 3454
2022
Q4
$152K Hold
2
﹤0.01% 3501
2022
Q3
$208K Hold
2
﹤0.01% 3364
2022
Q2
$250K Hold
2
﹤0.01% 3548
2022
Q1
$346K Hold
2
﹤0.01% 3404
2021
Q4
$541K Sell
2
-2
-50% -$541K ﹤0.01% 3038
2021
Q3
$2.21M Sell
4
-1
-20% -$554K ﹤0.01% 2011
2021
Q2
$3.59M Sell
5
-1
-17% -$717K ﹤0.01% 1846
2021
Q1
$6.39M Sell
6
-2
-25% -$2.13M 0.01% 1502
2020
Q4
$9.33M Sell
8
-1
-11% -$1.17M 0.01% 1220
2020
Q3
$2.23M Buy
9
+2
+29% +$495K ﹤0.01% 2066
2020
Q2
$1.9M Buy
7
+1
+17% +$272K ﹤0.01% 2213
2020
Q1
$670K Buy
6
+1
+20% +$112K ﹤0.01% 2616
2019
Q4
$1.56M Hold
5
﹤0.01% 2431
2019
Q3
$1.28M Buy
5
+1
+25% +$255K ﹤0.01% 2498
2019
Q2
$1.46M Buy
4
+1
+33% +$365K ﹤0.01% 2511
2019
Q1
$1.11M Hold
3
﹤0.01% 2620
2018
Q4
$1.9M Hold
3
﹤0.01% 2260
2018
Q3
$6.49M Hold
3
0.01% 1635
2018
Q2
$5.74M Buy
3
+1
+50% +$1.91M 0.01% 1700
2018
Q1
$2.45M Buy
2
+1
+100% +$1.23M ﹤0.01% 2222
2017
Q4
$1.82M Buy
+1
New +$1.82M ﹤0.01% 2394
2017
Q3
Hold
0
3008
2017
Q1
Hold
0
-$47K 3209
2016
Q4
Sell
-1
Closed -$663K 3166
2016
Q3
$663K Buy
+1
New +$663K ﹤0.01% 2726